2[2]ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J] . Eur Heart J , 2001,22:1852-1932
3[3]Wyse DG, Waldo AL, DiMarco JP, et al . The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation [J]. N Engl J Med ,2002 , 347:1825-1833
5[5]GoetteA,StaackT,RockenC,etal .Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation [J].J Am Coll Cardiol, 2000, 35:1669-1677
6[6]Madrid AH, Bueno MG, Rebollo JM, et al.Use of irbesartan to maintain sinusrhythm in patients with long-lasting persistent atrialfibrillation: a prospective and randomized study [J] .Circulation, 2002,106:331-336
7[7]Cain M E., Atrial Fibrillation - Rhythm or Rate Control[J].N Engl J Med, 2002, 347:1822-1823
8[8]Skoularigis J , Rothlisberger C, Skudicky D, et al .Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery[J] . Am J Cardiol 1993 ;72:423-427
